Menu
  • Join
  • Login
  • Contact
 

Search abstracts


THE METABOLISM PATHWAY AND DRUG-DRUG INTERACTIONS STUDY OF THSG

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: WU, Tien-Yuan (Tzu Chi University, Pharmacology, China Taiwan)
  • Co-author(s): Tien-Yuan Wu: Pharmacology, Tzu Chi University, Hualien, China Taiwan;Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, China Taiwan
    Guor-Jien Wei: Institute of Food Safety and Health Risk Assessment, National Yang Ming University, Taipei, China Taiwan
    Kuo-Wei Wei: Oncology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, China Taiwan
    Yu-Hui Ni: Oncology, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, China Taiwan
    Chi-Hua Chen: Pharmacy, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung City, China Taiwan
  • Abstract:

    Background

    Cancer chemotherapy patients undergoing integrated Chinese and Western medicine to reduce side effects and drug discomfort have been the current trend. However, the safety of combination of cancer chemotherapy drugs and Chinese herbal medicines has not been established. The drug drug interaction effects may be affected by drug..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses